Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance
Crossref DOI link: https://doi.org/10.1007/s12254-019-0488-3
Published Online: 2019-04-18
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Absenger, Gudrun
Text and Data Mining valid from 2019-04-18
Article History
Received: 10 January 2019
Accepted: 26 March 2019
First Online: 18 April 2019
Conflict of interest
: G. Absenger declares that she has no competing interests.